These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1314025)

  • 1. Filaments of Lewy bodies contain insoluble cytoskeletal elements.
    Galloway PG; Mulvihill P; Perry G
    Am J Pathol; 1992 Apr; 140(4):809-22. PubMed ID: 1314025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filaments of Pick's bodies contain altered cytoskeletal elements.
    Perry G; Stewart D; Friedman R; Manetto V; Autilio-Gambetti L; Gambetti P
    Am J Pathol; 1987 Jun; 127(3):559-68. PubMed ID: 3296772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination.
    Bancher C; Lassmann H; Budka H; Jellinger K; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM
    J Neuropathol Exp Neurol; 1989 Jan; 48(1):81-93. PubMed ID: 2462024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detergent-insoluble cortical Lewy body fibrils share epitopes with neurofilament and tau.
    Pollanen MS; Bergeron C; Weyer L
    J Neurochem; 1992 May; 58(5):1953-6. PubMed ID: 1373181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.
    Pollanen MS; Bergeron C; Weyer L
    Acta Neuropathol; 1994; 88(1):1-6. PubMed ID: 7524261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis.
    Murayama S; Mori H; Ihara Y; Bouldin TW; Suzuki K; Tomonaga M
    Ann Neurol; 1990 Feb; 27(2):137-48. PubMed ID: 2156479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ubiquitin and degenerative diseases of the central nervous system].
    Tranchant C; Muller S; Warter JM
    Rev Neurol (Paris); 1992; 148(12):731-5. PubMed ID: 1338933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia.
    Benitez-King G; Ramírez-Rodríguez G; Ortíz L; Meza I
    Curr Drug Targets CNS Neurol Disord; 2004 Dec; 3(6):515-33. PubMed ID: 15581421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.
    Dickson DW; Schmidt ML; Lee VM; Zhao ML; Yen SH; Trojanowski JQ
    Acta Neuropathol; 1994; 87(3):269-76. PubMed ID: 7912027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between Lewy bodies and pale bodies in Parkinson's disease.
    Dale GE; Probst A; Luthert P; Martin J; Anderton BH; Leigh PN
    Acta Neuropathol; 1992; 83(5):525-9. PubMed ID: 1320323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of modified Bielschowsky silver impregnation and anti-ubiquitin immunostaining of cortical and nigral Lewy bodies.
    Love S; Nicoll JA
    Neuropathol Appl Neurobiol; 1992 Dec; 18(6):585-92. PubMed ID: 1283205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit.
    Galvin JE; Lee VM; Baba M; Mann DM; Dickson DW; Yamaguchi H; Schmidt ML; Iwatsubo T; Trojanowski JQ
    Ann Neurol; 1997 Oct; 42(4):595-603. PubMed ID: 9382471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].
    Seitelberg F; Lassmann H
    Gac Med Mex; 1990; 126(5):367-73. PubMed ID: 1966495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and Diffuse Lewy body disease.
    Tortosa A; López E; Ferrer I
    Neurosci Lett; 1997 Nov; 238(1-2):78-80. PubMed ID: 9464659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.
    Galloway PG; Bergeron C; Perry G
    Neurosci Lett; 1989 May; 100(1-3):6-10. PubMed ID: 2548130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias.
    Trojanowski JQ; Schmidt ML; Shin RW; Bramblett GT; Rao D; Lee VM
    Brain Pathol; 1993 Jan; 3(1):45-54. PubMed ID: 8269083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology.
    Galloway PG; Perry G
    Brain Res; 1991 Feb; 541(2):347-9. PubMed ID: 2054646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.